Filter documents Clear search

pdf icon

CEU Statement: Weight and contraception (April 2017)

File size: 212kb | Date: 24 April 2017 | Clinical Statements - PDF

This statement summarises the available evidence regarding how contraception may affect a woman’s weight and how a woman’s weight may affect contraceptive efficacy. Looking at each method individually, the CEU advises clinicians on what proven and theoretical associations exist between contraception and weight.

pdf icon

CEU Statement: Management of women taking anticoagulants or antiplatelet medications who request intrauterine contraception or subdermal implants - March 2017

File size: 338kb | Date: 29 March 2017 | Clinical Statements - PDF

This statement aims to encourage the consistent and safe management of women requesting intrauterine contraception (IUC) and subdermal implants (SDI) who are taking anticoagulants or antiplatelet medications. It is primarily aimed at clinicians working in primary care and community sexual and reproductive health clinics.

pdf icon

CEU Statement: UK MEC 2016 Update (March 2017)

File size: 171kb | Date: 28 March 2017 | Clinical Statements - PDF

Change of UKMEC category for use of progestogen-only injectable contraception by women at high risk of HIV infection from UKMEC1 to UKMEC2

pdf icon

News item - Use of Nexplanon beyond three years - December 2016

File size: 110kb | Date: 4 December 2016 | Clinical Statements - PDF

A recently published multinational trial reports no pregnancies among 311 women who extended use of their existing Nexplanon® to four years and 204 women who continued to five years of use.[

pdf icon

CEU Statement: Pre-conception Care (August 2016)

File size: 167kb | Date: 23 August 2016 | Clinical Statements - PDF

Updated Document - Please note, this document was updated in September 2016. The previous version was published in August 2016.

pdf icon

CEU Statement: Contraception advice for individuals travelling to Brazil for the 2016 Olympics and their partners (revised 28 July 2016)

File size: 167kb | Date: 28 July 2016 | Clinical Statements - PDF

After reviewing the available body of evidence, the Centers for Disease Control (CDC) in the USA have concluded that a causal relationship exists between prenatal Zika virus infection and microcephaly and other serious brain anomalies. Cases of locally-transmitted Zika virus are still being reported in Brazil and most of its neighbouring countries.